[Modifications of immunoenzymatic aspects of B-cell chronic lymphocytic leukemia lymphocytes incubated in vitro with polyclonal B-cell activators and alpha-interferon].
Lanza
F
F
D000135:Acid Phosphatase / Q000097:blood; D002265:Carboxylic Ester Hydrolases / Q000097:blood; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000201:enzymology / Q000276:immunology*; D008934:Mitogens / Q000494:pharmacology; D011994:Recombinant Proteins; D000511:alpha-Macroglobulins / Q000494:pharmacology*
D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D008934:Mitogens; D011994:Recombinant Proteins; D000511:alpha-Macroglobulins; C032306:polyclonal B cell activator; D002265:Carboxylic Ester Hydrolases; C021855:naphthylbutyrate esterase; D000135:Acid Phosphatase
Modificazioni del quadro immunoenzimatico nei linfociti della B-LLC incubati in vitro con polyclonal B-cell activators e alfa-interferon.